[Xinyuan Real Estate Co., Ltd. to Hold Annual General Meeting of Shareholders on December 15, 2017 BEIJING, November 20, 2017 About Xinyuan Real Estate Co., Ltd. Xinyuan Xinyuan Real Estate Co., Ltd. (“ For more information, please contact: Xinyuan Real Estate Co., Ltd. Mr. Joe Xu Investor Relations ]
[Bitauto Announces Third Quarter 2017 Results Revenue increased 53.7% year-over-year Revenue from transaction services increased 145.7% year-over-year [1] BEIJING, November 20, 2017 /PRNewswire/ -- Bitauto Holdings Limited ("Bitauto" or the "Company") (NYSE: BITA), a leading provider of internet cont]
[XUNLEI ANNOUNCES UNAUDITED FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2017 Shenzhen, China, November 16, 2017 (GLOBE NEWSWIRE) – Xunlei Limited (“Xunlei” or the “Company”) (Nasdaq: XNET), a leading cloud-based acceleration technology company in China, today announced its unaudited f]
[XUNLEI ANNOUNCES UNAUDITED FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2017 Shenzhen, China, November 16, 2017 (GLOBE NEWSWIRE) – Xunlei Limited (“Xunlei” or the “Company”) (Nasdaq: XNET), a leading cloud-based acceleration technology company in China, today announced its unaudited f]
[China Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2018 2Q18 Added 23,647 New Subscribers 2Q18 Revenues Up 27.4% YOY to RMB234.6 Million ($35.3 Million) 2Q18 Operating Income Up 39.4% YOY to RMB76.3 Million ($11.5 Million) Conference Call to be Hel]
[China Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2018 2Q18 Added 23,647 New Subscribers 2Q18 Revenues Up 27.4% YOY to RMB234.6 Million ($35.3 Million) 2Q18 Operating Income Up 39.4% YOY to RMB76.3 Million ($11.5 Million) Conference Call to be Hel]
[FORM 10-Q (Mark One) ☒ September 30, 2017 For the quarterly period ended: Or ☐ For the transition period from ______________ to _______________ 001-34708 BIOSTAR PHARMACEUTICALS, INC. Maryland 20-8747899 (State or other jurisdiction of incorporation of origination) (I.R.S. Employer Identification Nu]
[FORM 10-Q (Mark One) ☒ September 30, 2017 For the quarterly period ended: Or ☐ For the transition period from ______________ to _______________ 001-34708 BIOSTAR PHARMACEUTICALS, INC. Maryland 20-8747899 (State or other jurisdiction of incorporation of origination) (I.R.S. Employer Identification Nu]
[FORM 10−Q (Mark One) [X] September 30, 2017 For the quarterly period ended: [ ] For the transition period from _____________ to _____________ 001-32898 CBAK ENERGY TECHNOLOGY, INC. Nevada 88-0442833 (State or other jurisdiction of (I.R.S. Employer Identification No.) incorporation or organization) B]
[FORM 10−Q (Mark One) [X] September 30, 2017 For the quarterly period ended: [ ] For the transition period from _____________ to _____________ 001-32898 CBAK ENERGY TECHNOLOGY, INC. Nevada 88-0442833 (State or other jurisdiction of (I.R.S. Employer Identification No.) incorporation or organization) B]
